Pieris Pharma (PIRS) Reports Q1 Loss of $0.19/Share

Pieris Pharma (NASDAQ: PIRS) reported Q1 EPS of ($0.19), versus ($0.10) reported last year. Revenue for the quarter came in at $1.34 million, versus $1.25 million reported last year.

For earnings history and earnings-related data on Pieris Pharma (PIRS) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c